rat
inject
fraction
mlkg
dose
fluosol
da
without
exposur
oxygen
anim
kill
day
posttreat
sampl
taken
hematolog
hepat
enzym
histolog
perfluorochem
analys
signific
differ
hemogram
hepat
enzym
find
treatment
control
group
differ
organ
weight
histolog
result
periluorochem
pfc
accumul
tissu
treat
anim
chang
revers
effect
breath
high
oxygen
level
either
treatment
control
anim
oxygen
recogn
power
radiosensit
agent
solid
tumor
area
vascular
insuffici
necrosi
may
caus
cell
chronic
hypox
consequ
resist
radiat
chemic
radiosensit
use
attempt
enhanc
radiat
effect
hypox
cell
fraction
limit
clinic
success
teicher
rose
rockwel
shown
administr
fluosolda
oxygen
carri
perfluorochem
pfc
emuls
oxygen
co
tumorbear
mice
prior
radiat
significantli
delay
tumor
regrowth
howev
clinic
treatment
cours
may
requir
multipl
fluosol
infus
studi
design
assess
possibl
effect
multipl
fluosol
dose
reticuloendotheli
system
re
compar
effect
multipl
infus
previou
work
use
singl
bolu
dose
male
spraguedawley
rat
gm
divid
four
group
per
group
control
room
air
cra
control
oxygen
cox
fluosol
room
air
fra
fluosol
oxygen
fox
treatment
anim
receiv
total
mlkg
pfc
kg
bodi
weight
fluosol
mlkg
bolu
dose
via
tail
vein
treatment
day
control
anim
inject
cox
fox
anim
receiv
oxygen
three
hour
daili
first
weekday
treatment
day
anim
group
kill
exsanguin
day
posttreat
blood
sampl
obtain
death
analyz
sgot
sgpt
alkalin
phosphatas
hemoglobin
red
white
cell
level
tissu
sampl
obtain
lung
liver
spleen
histolog
analys
perform
use
weigh
sampl
fix
formalin
pfc
extract
tissu
yamanouchi
et
quantit
ga
chromatograph
use
known
perlluorotripropylamin
fipa
pertluorodecalin
fdc
standard
serum
randomli
select
anim
screen
antibodi
murin
pneumonia
viru
corona
viru
sendai
viru
mycoplasma
slight
differ
note
treatment
control
liver
enzym
hemogram
valu
alkalin
phosphatas
level
somewhat
lower
p
fox
group
f
iul
mean
standard
deviat
cox
group
iul
day
posttreat
similarli
lower
iul
cra
f
iul
cox
iul
group
day
posttreat
differ
p
sgot
level
iul
fox
iul
group
seen
day
posttreat
differ
treatment
control
sgpt
valu
white
blood
cell
count
fra
fox
x
day
x
day
posttreat
slightli
elev
p
cra
cox
valu
x
control
day
x
day
posttreat
reason
elev
unknown
count
resolv
observ
effect
anim
serolog
result
show
low
level
mycoplasma
titer
anim
treatment
control
group
pfc
analysi
reveal
mark
ftpa
fdc
accumul
spleen
liver
fra
fox
anim
day
posttreat
tabl
pfc
accumul
pronounc
spleen
f
mggm
ftpa
mggm
fdc
recov
fox
anim
similar
pfc
amount
recov
fra
anim
day
posttreat
less
mggm
total
pfc
recov
lung
tissu
pfc
content
tissu
decreas
time
fdc
clear
rapidli
ftpa
organ
end
studi
measur
fdc
mggm
remain
spleen
fipa
recov
spleen
mggm
liver
mggm
day
posttreat
howev
fdc
ftpa
clearanc
essenti
complet
lung
tissu
six
month
posttreat
fluosol
accumul
cell
observ
re
spleen
liver
fluosol
treat
anim
spleen
mark
accumul
foami
macrophag
throughout
red
pulp
day
posttreat
fig
accumul
also
observ
lymphoid
germin
follicl
sampl
chang
remain
promin
day
posttreat
day
remain
mild
moder
focal
accumul
foami
macrophag
red
pulp
accumul
germin
center
fig
day
posttreat
liver
anim
treatment
group
contain
moder
number
larg
foami
kupffer
cell
enlarg
foami
hepatocyt
fig
reflect
accumul
fluosoi
cell
cell
decreas
number
gradual
scatter
foami
cell
observ
day
posttreat
fig
scatter
foami
macrophag
observ
alveoli
interstitium
lung
tissu
treatment
anim
day
day
posttreat
occasion
foami
cell
observ
control
tissu
sampl
histolog
normal
except
evid
mycoplasmosi
observ
lung
control
treatment
anim
light
microscop
examin
reveal
tissu
damag
although
foami
macrophag
indic
whole
bodi
weight
increas
rel
organ
weight
decreas
time
group
reflect
growth
anim
differ
whole
bodi
weight
fra
anim
control
anim
studi
howev
fox
group
weight
gain
depress
p
day
time
control
day
time
control
posttreat
return
control
level
termin
studi
etiolog
weight
chang
examin
expect
liver
spleen
weight
initi
elev
fluosol
treatment
tabl
anim
receiv
fluosol
rel
liver
weight
time
rel
weight
correspond
control
day
posttreat
p
spleen
increas
time
control
weight
observ
fra
fox
group
respect
p
differ
resolv
gradual
time
almost
complet
normal
day
posttreat
differ
organ
weight
attribut
inspir
high
oxygen
either
control
treatment
group
differ
lung
weight
observ
treatment
control
group
administr
fluosol
multipl
dose
total
mlkg
result
markedli
advers
effect
anim
test
perfluorochem
histolog
analys
confirm
pfc
taken
re
previous
report
histolog
examin
confirm
accumul
pfccontain
foami
macrophag
without
structur
inflammatori
chang
previou
light
electron
microscop
studi
monkey
inject
perfluorochem
emuls
also
document
pfccontain
macrophag
re
without
damag
tissu
architectur
pfc
content
liver
spleen
decreas
time
organ
weight
normal
correspondingli
fewer
macrophag
observ
clearanc
took
place
studi
clearanc
pfc
organ
similar
report
use
singl
gmkg
pfc
dose
howev
rate
clearanc
appear
prolong
studi
use
exchang
transfus
rapid
clearanc
fdc
organ
observ
previou
reflect
differ
elimin
rate
constant
two
pfc
slight
pfc
accumul
note
lung
small
number
foami
macrophag
observ
also
decreas
time
pfc
elimin
bodi
primarili
expir
lung
studi
although
pfc
detect
lung
structur
damag
due
pfc
transport
observ
hemogram
serolog
hepat
enzym
valu
affect
fluosol
administr
differ
observ
hepat
enzym
attribut
random
variat
individu
anim
indic
liver
dysfunct
result
pluosol
infus
transient
alter
sggt
sgpt
alkalin
phosphatas
wbc
count
preclin
clinic
studi
attribut
patholog
respons
metzenau
report
transient
elev
hepat
enzym
administr
fluosol
gm
pfckg
howev
rapid
return
enzym
control
level
suggest
organ
damag
mark
dysfunct
depress
whole
bodi
weight
gain
observ
fox
group
compar
cra
cox
group
day
posttreat
data
obtain
studi
suggest
explan
differ
howev
surmis
extra
handl
anim
fox
group
studi
contribut
depress
weight
gain
goodman
et
al
report
fivefold
increas
spleen
weight
twofold
increas
liver
weight
follow
multipl
infus
pluosol
gm
pfckg
total
dose
data
show
fold
increas
liver
spleen
weight
respect
reason
differ
observ
spleen
weight
known
howev
studi
also
fail
show
compar
splenic
enlarg
similar
fluosol
increas
spleen
liver
weight
observ
treat
anim
reflect
pfc
storag
organ
agreement
previou
work
total
weight
gain
liver
spleen
observ
studi
exce
amount
pfc
retain
organ
gain
attribut
either
hyperplasia
hypertrophi
data
report
permit
elucid
mechan
weight
gain
organ
anoth
studi
chang
fibroid
tissu
observ
liver
lung
within
one
year
follow
multipl
dose
fluosol
total
gm
pfckg
bodi
result
report
studi
indic
fluosol
mark
detriment
effect
dosag
level
suggest
effect
follow
multipl
inject
gm
pfckg
mlkg
similar
result
obtain
bolu
inject
fluosol
mlkg
